Glycogen Synthase Kinase 3β: A New Gold Rush in Anti-Alzheimer’s Disease Multitarget Drug Discovery?: Miniperspective

[Image: see text] Alzheimer’s disease (AD), like other multifactorial diseases, is the result of a systemic breakdown of different physiological networks. As result, several lines of evidence suggest that it could be more efficiently tackled by molecules directed toward different dysregulated bioche...

Descripción completa

Detalles Bibliográficos
Autores principales: De Simone, Angela, Tumiatti, Vincenzo, Andrisano, Vincenza, Milelli, Andrea
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Chemical Society 2020
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8016207/
https://www.ncbi.nlm.nih.gov/pubmed/33346659
http://dx.doi.org/10.1021/acs.jmedchem.0c00931

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8016207/
https://www.ncbi.nlm.nih.gov/pubmed/33346659
http://dx.doi.org/10.1021/acs.jmedchem.0c00931

Ejemplares similares